GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » Tax Expense

Jamjoom Pharmaceuticals Factory Co (SAU:4015) Tax Expense : ﷼26 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co Tax Expense?

Jamjoom Pharmaceuticals Factory Co's tax expense for the months ended in Dec. 2024 was ﷼7 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ﷼26 Mil.


Jamjoom Pharmaceuticals Factory Co Tax Expense Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co Tax Expense Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense
24.88 17.39 15.00 23.40 26.13

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 9.76 3.24 6.27 6.86

Jamjoom Pharmaceuticals Factory Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jamjoom Pharmaceuticals Factory Co  (SAU:4015) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Jamjoom Pharmaceuticals Factory Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Jamjoom Pharmaceuticals Factory Co Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box No. 6267, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines